Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
358.00    2.00 (0.56%)
Bid:
354.00
Ask:
356.50
Spread: 2.50 (0.706%)
Market Cap: £1.83b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

27 Jun 2025 15:00

RNS Number : 8122O
Caledonia Investments PLC
27 June 2025
 

Caledonia Investments plc

 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the UK Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving one of its directors, Jamie Cayzer-Colvin.

 

On 25 June 2025, 16,186 Shares, as noted in the table below, were transferred to Mr Cayzer-Colvin under the Caledonia Investments 2011 Performance Share Scheme ("2011 PSS") and the Caledonia Investments 2020 Deferred Bonus Plan ("DBP") at nil cost. The Shares were sourced from The Caledonia Investments plc Employee Share Trust ("EST"). 

 

Director

2011 PSS

DBP

J M B Cayzer-Colvin

11,520

4,666

 

On the same date, Mr Cayzer-Colvin sold:

 

· 7,630 Shares to the EST to meet the tax liability due; and

· 1,822 Shares to a member of the Cayzer family concert party.

 

Mr Cayzer-Colvin retained 6,734 Shares.

 

Following the above transactions, Mr Cayzer-Colvin's beneficial interests in the Company increased. 

 

Each of these transactions were conducted on-market in London. The Shares were sold to the EST and a member of the Cayzer family concert party at 3712.5p per Share.

 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows: 

 

Description

Number of Shares

Percentage of voting rights

Beneficial

250,969

0.477%

Non-beneficial

203,754

0.387%

Performance share scheme awards

98,559

0.187%

Deferred bonus plan awards

1,488

0.003%

 

Further information required by the UK Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

 

Enquiries:

Richard Webster

Company Secretary

Tel: +44 20 7802 8080

 

27 June 2025

 

APPENDIX

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary 5p shares

 

 

GB0001639920

 

b)

 

Nature of the transaction

 

 

1. Exercise of Caledonia Investments 2011 Performance Share Scheme ("PSS") award

 

2. Exercise of Caledonia Investments 2020 Deferred Bonus Plan ("DBP") award

 

3. Partial sale of shares arising from PSS and DBP exercise to The Caledonia Investments plc Employee Share Trust ("EST")

 

4. Partial sale of shares to a member of the Cazyer family concert party

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS award

 

 

2. Exercise of DBP award

 

 

3. Partial sale of shares arising from PSS award and DBP award to the EST

4. Partial sale of shares to a member of the Cazyer family concert party

 

Price(s)

 

Volume(s)

£nil

 

 

11,520

£nil

 

 

4,666

£37.125

 

 

7,630

£37.125

 

 

1,822

 

d)

 

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

N/A (single transaction)

e)

 

Date of the transaction

 

 

25 June 2025

f)

 

Place of the transaction

 

XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDLDGDDGUR
Date   Source Headline
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20269:57 amRNSDirector/PDMR Shareholding
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 202611:00 amRNSNet Asset Value(s)
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 202610:30 amRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSFunds spotlight event
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 202611:36 amRNSDirector/PDMR Shareholding
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 202611:00 amRNSAppointment of non-executive director
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20263:00 pmRNSDirector/PDMR Shareholding
12th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSNet Asset Value(s)
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20251:36 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 202511:00 amRNSNet Asset Value(s)
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTotal Voting Rights
28th Nov 20255:04 pmRNSDirector/PDMR Shareholding
28th Nov 20252:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.